New Advantage 24 contraceptive gel claims 24-hour effectiveness. But proposed FDA rule could put N-9 products to the test.
D000569:Americas; D003257:Consumer Product Safety; D003267:Contraception; D003270:Contraceptive Agents; D019049:Developed Countries; D005193:Family Planning Services; D006077:Government Agencies; D019359:Knowledge; D008004:Licensure; D017137:Nonoxynol; D009656:North America; D009938:Organizations; D013089:Spermatocidal Agents; D014481:United States; D014486:United States Food and Drug Administration; D014492:United States Public Health Service; D014622:Vaginal Creams, Foams, and Jellies
D003270:Contraceptive Agents; D013089:Spermatocidal Agents; D014622:Vaginal Creams, Foams, and Jellies; D017137:Nonoxynol
Americas; Contraception; Contraceptive Agents--side effects; Contraceptive Effectiveness; Contraceptive Methods--standards; Developed Countries; Family Planning; Government Agencies; Knowledge; Licensing; Nonoxynol-9--side effects; North America; Northern America; Organizations; Product Approval; Spermicidal Contraceptive Agents--side effects; United States; Usfda; Usphs; Vaginal Jelly--standards; Vaginal Spermicides--standards